Consensus Cardinal Health, Inc.

Equities

CAH

US14149Y1082

Market Closed - Nyse 04:00:02 2024-03-18 pm EDT 5-day change 1st Jan Change
110.2 USD -0.41% Intraday chart for Cardinal Health, Inc. -4.61% +9.29%

Evolution of the average Target Price on Cardinal Health, Inc.

Price target over the last 5 years

History of analyst recommendation changes

ddf0fea3701048b679573851945ecea2.fzO6NLNVHXsmGmrMQP8D16MFSBSmItLh0yC8u4LhGJ8.GWfCXvkwcxhkaiWkOo12k891LnPpe5ep62fFzfSQUPszZ90D9WUqA2RJGQ~328bd2e185851b32e359cef4cbd120e3
Leerink Partners Starts Cardinal Health With Outperform Rating, $125 Price Target MT
Argus Upgrades Cardinal Health to Buy From Hold, Price Target is $120 MT
UBS Adjusts Cardinal Health Price Target to $125 From $122, Maintains Buy Rating MT
UBS Raises Cardinal Health Price Target to $122 From $114, Maintains Buy Rating MT
Wells Fargo Starts Coverage on Cardinal Health with Underweight Rating, $96 Price Target MT
JPMorgan Raises Cardinal Health's Price Target to $112 From $101, Maintains Neutral Rating MT
Investors see life through rose-colored glasses Our Logo
ANALYST RECOMMENDATIONS : Air Products & Chemicals, Barclays, Glencore, Mastercard, Walmart... Our Logo
Deutsche Bank Raises Cardinal Health Price Target to $105 From $102, Maintains Hold Rating MT
UBS Adjusts Cardinal Health Price Target to $114 From $110, Maintains Buy Rating MT
ANALYST RECOMMENDATIONS : Asos, Blackstone, Fortinet, Hershey, Wizz Air... Our Logo
ANALYST RECOMMENDATIONS : Microsoft, Oracle, Adobe, Qualcomm, 3M... Our Logo
Deutsche Bank Adjusts Cardinal Health Price Target to $102 From $90, Maintains Hold Rating MT
CORRECTION : Morningstar Upgrades Cardinal Health to Hold From Sell, Adjusts Price Target to $85 From $67 MT
Nephron Research Increases Price Target on Cardinal Health to $107 From $99, Maintains Buy Rating MT
Morningstar Downgrades Cardinal Health to Hold From Sell, Adjusts Price Target to $85 From $67 MT
TD Cowen Adjusts Price Target on Cardinal Health to $90 From $88, Keeps Market Perform Rating MT
JPMorgan Chase Raises Price Target on Cardinal Health to $101 From $93, Maintains Neutral Rating MT
Mizuho Adjusts Price Target on Cardinal Health to $96 From $94, Maintains Neutral Rating MT
Morgan Stanley Adjusts Price Target on Cardinal Health to $100 From $92, Maintains Overweight Rating MT
Baird Adjusts Price Target on Cardinal Health to $108 From $107, Keeps Outperform Rating MT
UBS Adjusts Cardinal Health Price Target to $107 From $97, Maintains Buy Rating MT
Mizuho Raises Price Target on Cardinal Health to $94 From $85, Maintains Neutral Rating MT
Evercore ISI Group Downgrades Cardinal Health to In Line From Outperform, Price Target is $100 MT
Citigroup Adjusts Price Target on Cardinal Health to $90 From $88, Maintains Neutral Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
110.2 USD
Average target price
113.3 USD
Spread / Average Target
+2.86%
High Price Target
133 USD
Spread / Highest target
+20.73%
Low Price Target
93 USD
Spread / Lowest Target
-15.58%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cardinal Health, Inc.

Leerink Partners
Argus
UBS
Wells Fargo Securities
JPMorgan Chase
Deutsche Bank Securities
Nephron Research
Morningstar
TD Cowen
Mizuho Securities
Morgan Stanley
Baird
Evercore ISI
Citigroup
Barclays
Credit Suisse
Cowen
BofA Securities
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings